デフォルト表紙
市場調査レポート
商品コード
997422

犬幹細胞治療の世界市場

Canine Stem Cell Therapy

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 179 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

犬幹細胞治療の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の犬幹細胞治療の市場規模は、分析期間(2020年~2027年)に4%のCAGRで成長する見通しで、2020年の1億6,170万米ドルから、2027年には2億1,270万米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つである同種幹細胞は、分析期間中に4.5%のCAGRで成長し、1億4,690万米ドルに達すると予測されています。

当レポートは、世界の犬幹細胞治療市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:47社
目次
Product Code: MCP10870

Abstract:

Global Canine Stem Cell Therapy Market to Reach $212.7 Million by 2027

Amid the COVID-19 crisis, the global market for Canine Stem Cell Therapy estimated at US$161.7 Million in the year 2020, is projected to reach a revised size of US$212.7 Million by 2027, growing at aCAGR of 4% over the period 2020-2027. Allogeneic Stem Cells, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$146.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Autologous Stem Cells segment is readjusted to a revised 3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $47.6 Million, While China is Forecast to Grow at 3.8% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$47.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$37.8 Million by the year 2027 trailing a CAGR of 3.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Select Competitors (Total 47 Featured) -

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Autologous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Veterinary Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Veterinary Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Veterinary Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 19: USA Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 20: USA Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 21: USA 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 22: USA Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 25: Canada Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Canada Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 27: Canada 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 28: Canada Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 31: Japan Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Japan Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 33: Japan 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 34: Japan Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 37: China Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 38: China Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 39: China 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 40: China Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 43: Europe Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 44: Europe Historic Review for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 45: Europe 15-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 46: Europe Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 52: France Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 53: France Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 54: France 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 55: France Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 58: Germany Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Germany Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 60: Germany 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 61: Germany Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 64: Italy Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Italy Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 66: Italy 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 67: Italy Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 70: UK Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 71: UK Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 72: UK 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 73: UK Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Rest of Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 78: Rest of Europe 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 79: Rest of Europe Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 81: Rest of Europe 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 82: Asia-Pacific Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Asia-Pacific Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 84: Asia-Pacific 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 85: Asia-Pacific Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 87: Asia-Pacific 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 88: Rest of World Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of World Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of World 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
    • TABLE 91: Rest of World Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of World 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 47